Costunolide Reduces DN Inflammatory Response and Renal Thrombosis by Inhibiting NET Formation
Conclusion: COS alleviates inflammation and platelet activation–mediated thrombosis in DN mice, potentially by inhibiting excessive NET formation. These findings highlight the therapeutic potential of COS in managing DN.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/jdr/1159325 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|